Antag Therapeutics
biopharmaceutical company developing new treatments for obesity
Antag Therapeutics has raised €80M across 1 funding round from 7 investors, most recently a Series A round in Dec 2024. Based in Copenhagen, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Copenhagen, Denmarkantagtherapeutics.com ↗
Total raised
€80M
€80,000,000
Funding rounds
1
Investors
7
distinct backers
Active since
2024-12
latest 2024-12
Funding by year
EUR raised per yearAntag Therapeutics — funding by year — interactive chart.
Data table
| Antag Therapeutics — funding by year | |
|---|---|
| 2024 | €80M |
Signals
High confidenceRaise-next likelihood56
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-04 | Series A | €80M | Dawn Biopharma,Export and Investment Fund of Denmark (EIFO),Longview Ventures,Novo Holdings,Pictet,SR One+1 more | View deal → |
Investors
7Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData